Linlin Xie

690 citations
26 papers · 514 indexed · h-index 11
Topics
Corporate Finance and Governance (3 papers)Renal Transplantation Outcomes and Treatments (2 papers)Hormonal and reproductive studies (2 papers)
Journals
SHILAP Revista de lepidopterologíaScientific ReportsChemical Engineering Journal
Partner nations
ChinaBangladeshHong Kong

In The Last Decade

Linlin Xie

25 papers receiving 509 citations

Peers

Linlin Xie
Comparison fields: 5 of 117
  • Infectious Diseases 172
  • Neurology 107
  • Molecular Biology 104
  • Oncology 51
  • Epidemiology 47
Replace Nour K. Younis with:
Nour K. Younis Lebanon
Bartosz Szostak Poland
Layla Shojaie United States
Sangjin Lee South Korea
Frederik E. Stuurman Netherlands
Yong Han China
Gaoming Li China
Martin Šíma Czechia
Maryam Ebadi United States
Linlin Xie relative to Nour K. Younis Lebanon Nour K. Younis's profile →
Citations per field
00.5×10×13.5×
Nour K. Younis · 1×
Citations per year

Countries citing papers authored by Linlin Xie

Since Specialization
Citations

This map shows the geographic impact of Linlin Xie's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Linlin Xie with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Linlin Xie more than expected).

Fields of papers citing papers by Linlin Xie

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Linlin Xie. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Linlin Xie. The network helps show where Linlin Xie may publish in the future.

Co-authorship network of co-authors of Linlin Xie

This figure shows the co-authorship network connecting the top 25 collaborators of Linlin Xie. A scholar is included among the top collaborators of Linlin Xie based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Linlin Xie. Linlin Xie is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 10
2 9
3 3
4 27
5 7
6 31
7 7
8 25
9 23
10 23
11 26
12 10
13 7
14 5
15 16
16 10
17 10
18 27
19 3
20 8

About Linlin Xie

Linlin Xie is a scholar working on Transplantation, Biological Psychiatry and Pharmacology, having authored 26 papers that have together received 514 indexed citations. Recurring topics across this work include Corporate Finance and Governance (3 papers), Renal Transplantation Outcomes and Treatments (2 papers) and Hormonal and reproductive studies (2 papers). The work is most often cited by research in Infectious Diseases (172 citations), Neurology (107 citations) and Transplantation (19 citations). Linlin Xie has collaborated with scholars based in China, Bangladesh and Hong Kong. Frequent co-authors include Yong Feng, Wei Hou, Chengliang Zhu, Lang Chen, Kailang Wu, Fang Liu, Huan Han, Jie Yang, Rui Liu and Minghao Chen. Their work appears in journals such as SHILAP Revista de lepidopterología, Scientific Reports and Chemical Engineering Journal.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026